Senji Hoshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Senji Hoshi has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Isoji Sasagawa
Department of Urology Yamagata Tokushukai Hospital Yamagata Japan
2 shared publicationsKenji Numahata
Department of Urology Yamagata Prefectural Central Hospital Yamagata Japan
2 shared publications- Vladimir Bilim
Department of Urology, Kameda Daiichi Hospital, Niigata 950-0165, Japan
2 shared publications Akito Kuromoto
Department of Urology Yamagata Prefectural Central Hospital Yamagata Japan
1 shared publication- Isoji Sasagawa
Department of Urology, Yamagata Tokushukai Hospital, Yamagata 990-0834, Japan
1 shared publication Keiji Horio
Department of Radiology, Yamagata Tokushukai Hospital, Yamagata, Yamagata 990‑0834, Japan
1 shared publication
Latest Publications
- Open Access
- 11 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 510
Double Primary Cancer of the Prostate and Urothelial Cancer: A Single Institution Experience
Prostate cancer (PCa) ranks as the second most common cancer in Japanese males, while bladder cancer (BC) holds the tenth spot. Among double urological cancers, the incidence of synchronous or metachronous BC and PCa is the highest. Reports on upper urinary tract (UUT) urothelial cancer (UC) in PCa patients are limited. Here, we present three cases of metachronous PCa and BC, with subsequent diagnosis of ureteral and renal pelvic cancer during the course of the disease. In the follow-up of patients with urological cancers, it is important to be aware not only of the progression of the initial cancer but also the potential development of a second cancer.
- 11 May 2024
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (5) , 510
Open AccessDouble Primary Cancer of the Prostate and Urothelial Cancer: A Single Institution Experience
Prostate cancer (PCa) ranks as the second most common cancer in Japanese males, while bladder cancer (BC) holds the tenth spot. Among double urological cancers, the incidence of synchronous or metachronous BC and PCa is the highest. Reports on upper urinary tract (UUT) urothelial cancer (UC) in PCa patients are limited. Here, we present three cases of metachronous PCa and BC, with subsequent diagnosis of ureteral and renal pelvic cancer during the course of the disease. In the follow-up of patients with urological cancers, it is important to be aware not only of the progression of the initial cancer but also the potential development of a second cancer.
- Open Access
- 14 December 2018
- Published by Wiley in IJU Case Reports
- Vol. 2 (1) , 47-50
Bladder cancer metastasis producing beta‐human chorionic gonadotropin, squamous cell carcinoma antigen, granulocyte‐colony stimulating factor, and parathyroid hormone‐related protein
Introduction In urothelial cancer, several paraneoplastic syndromes can be triggered by the aberrant expression of hormones, growth factors or lymphokines by tumor cells. Case presentation A 71‐year‐old female patient underwent radical cystectomy for muscle‐invasive urothelial cancer. Shortly after the operation, the patient presented with a leukemoid reaction and hypercalcemia. Computed tomography scans revealed a rapidly progressing tumor on the left pelvic side, and serum levels of granulocyte‐colony stimulating factor, parathyroid hormone‐related protein, and beta human chorionic gonadotropin were elevated. The patient also tested positive for serum squamous cell carcinoma antigen. Hypercalcemia was successfully treated with denosumab. However, the patient's leukocyte counts steadily increased, her condition deteriorated and she passed away. Conclusion To the best of our knowledge, this is the first report of urothelial cancer that tested positive for four tumor markers. The findings support the idea that poorly differentiated bladder carcinomas can ectopically secrete multiple proteins causing pleiotropic paraneoplastic syndromes.
- 14 December 2018
- Published by Wiley in IJU Case Reports
- Vol. 2 (1) , 47-50
Open AccessBladder cancer metastasis producing beta‐human chorionic gonadotropin, squamous cell carcinoma antigen, granulocyte‐colony stimulating factor, and parathyroid hormone‐related protein
Introduction In urothelial cancer, several paraneoplastic syndromes can be triggered by the aberrant expression of hormones, growth factors or lymphokines by tumor cells. Case presentation A 71‐year‐old female patient underwent radical cystectomy for muscle‐invasive urothelial cancer. Shortly after the operation, the patient presented with a leukemoid reaction and hypercalcemia. Computed tomography scans revealed a rapidly progressing tumor on the left pelvic side, and serum levels of granulocyte‐colony stimulating factor, parathyroid hormone‐related protein, and beta human chorionic gonadotropin were elevated. The patient also tested positive for serum squamous cell carcinoma antigen. Hypercalcemia was successfully treated with denosumab. However, the patient's leukocyte counts steadily increased, her condition deteriorated and she passed away. Conclusion To the best of our knowledge, this is the first report of urothelial cancer that tested positive for four tumor markers. The findings support the idea that poorly differentiated bladder carcinomas can ectopically secrete multiple proteins causing pleiotropic paraneoplastic syndromes.
- 7 September 2018
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 9 (5) , 515-518
Usefulness of multi‑parametric MRI for diagnosis of invasive urothelial cancer: Case reports of bladder and ureteral cancer
The presence or absence of metastasis has critical implications for therapeutic decision‑making in urothelial cancer (UC). Conventional magnetic resonance imaging (MRI) utilizing anatomic T1‑ and T2‑weighted images has modest efficacy in detecting lymph node and distant metastases in UC. However, incorporation of functional techniques including diffusion weighted imaging and dynamic contrast‑enhanced imaging, may improve the accuracy of lesion detection and staging. Multiparametric (mp)MRI is widely used in the imaging of prostate and breast cancers, though its usefulness in UC has yet to be fully elucidated. The present study reports on mpMRI in the context of two cases of bladder and ureteral cancer, and imaging results with pathological diagnosis.
- 7 September 2018
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 9 (5) , 515-518
Usefulness of multi‑parametric MRI for diagnosis of invasive urothelial cancer: Case reports of bladder and ureteral cancer
The presence or absence of metastasis has critical implications for therapeutic decision‑making in urothelial cancer (UC). Conventional magnetic resonance imaging (MRI) utilizing anatomic T1‑ and T2‑weighted images has modest efficacy in detecting lymph node and distant metastases in UC. However, incorporation of functional techniques including diffusion weighted imaging and dynamic contrast‑enhanced imaging, may improve the accuracy of lesion detection and staging. Multiparametric (mp)MRI is widely used in the imaging of prostate and breast cancers, though its usefulness in UC has yet to be fully elucidated. The present study reports on mpMRI in the context of two cases of bladder and ureteral cancer, and imaging results with pathological diagnosis.